0000899243-19-003843.txt : 20190215 0000899243-19-003843.hdr.sgml : 20190215 20190215160901 ACCESSION NUMBER: 0000899243-19-003843 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190201 FILED AS OF DATE: 20190215 DATE AS OF CHANGE: 20190215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Henn Matthew R. CENTRAL INDEX KEY: 0001767321 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37465 FILM NUMBER: 19611593 MAIL ADDRESS: STREET 1: C/O SERES THERAPEUTICS, INC. STREET 2: 200 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seres Therapeutics, Inc. CENTRAL INDEX KEY: 0001609809 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 274326290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617 945 9626 MAIL ADDRESS: STREET 1: 200 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Seres Health, Inc. DATE OF NAME CHANGE: 20140603 3/A 1 doc3a.xml FORM 3/A SUBMISSION X0206 3/A 2019-02-01 2019-02-11 0 0001609809 Seres Therapeutics, Inc. MCRB 0001767321 Henn Matthew R. C/O SERES THERAPEUTICS, INC. 200 SIDNEY STREET CAMBRIDGE MA 02139 0 1 0 0 Chief Scientific Officer Stock Option (Right to Buy) 0.71 2016-09-19 2024-08-06 Common Stock 26000 D These options were inadvertently omitted from the reporting person's original Form 3 filed on February 11, 2019. /s/ Thomas J. DesRosier, Attorney-in-fact 2019-02-15